FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Testosterone Cypionate Injection Recall

Testosterone Cypionate Injection, USP, 200 mg/mL, Rx only, 10 mL vials, Distributed by:…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class II
Reported by FDA
Aug 1, 2018
Recall ID
D-0977-2018
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Testosterone Cypionate Injection starting Jul 12, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0977-2018 on Aug 1, 2018. Reason: Presence of Particulate Matter: organic and inorganic compounds detected in vials of product. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: organic and inorganic compounds detected in vials of product.

Product description

Testosterone Cypionate Injection, USP, 200 mg/mL, Rx only, 10 mL vials, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-016-40

Lot numbers, UPCs & expiration codes

Lot #: JKS0280A, Exp. 06/2019

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0977-2018
Classification
Class II
Status
Terminated
Recall initiated
Jul 12, 2018
FDA report date
Aug 1, 2018
Quantity
5215 units
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0977-2018, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
80485
Address
270 Prospect Plains Rd
Code information
Lot #: JKS0280A, Exp. 06/2019
Postal code
08512-3605
Report date
Aug 1, 2018
Product type
Drugs
Recall number
D-0977-2018
Classification
Class II
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
5215 units
Termination date
Mar 11, 2019
Reason for recall
Presence of Particulate Matter: organic and inorganic compounds detected in vials of product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone Cypionate Injection, USP, 200 mg/mL, Rx only, 10 mL vials, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-016-40
Distribution pattern
Nationwide within the United States
Recall initiation date
Jul 12, 2018
Initial firm notification
Letter
Center classification date
Jul 24, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0977-2018, published Aug 1, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls